Aquestive was founded over 20 years ago on the promise of PharmFilm, our patented drug delivery method that enables precise oral delivery of almost any active pharmaceutical ingredient (API). PharmFilm isn’t just the technology behind two of our pipeline candidates—it’s also utilized by our strategic licensees who commercialize millions of doses of PharmFilm every year.

Aquestive's new AdrenaVerse prodrug platform is a breakthrough technology that allows precise control of epinephrine absorption and release across mucosal surfaces and skin. By converting inactive epinephrine into its active form at the site of inflammation, AdrenaVerse enables targeted treatment with sustained duration, minimal side effects, and broad potential across allergic and dermatologic indications.

PharmFilm® is a unique and versatile technology for high-performance drug delivery. A small, postage-stamp sized film is taken orally, allowing for fast absorption of the active ingredient without the need for water or liquids. All routes of administration allow for direct entry into the bloodstream, without needles, pills, or injections. PharmFilm strips are packaged in child-proof foil pouches, which are resistant to water, extremely durable, and allow for on-the-go convenience.



